HESTER BIOSCIENCES
Back to Income Statement
|
HESTER BIOSCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹311 Cr | ₹305 Cr | ₹266 Cr | ₹235 Cr | ₹214 Cr |
What is the latest Revenue of HESTER BIOSCIENCES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹311 Cr |
| Mar2025 | ₹305 Cr |
| Mar2024 | ₹266 Cr |
| Mar2023 | ₹235 Cr |
| Mar2022 | ₹214 Cr |
How is Revenue of HESTER BIOSCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹311 Cr | 2.15 | |
| Mar2025 | ₹305 Cr | 14.45 | |
| Mar2024 | ₹266 Cr | 13.23 | |
| Mar2023 | ₹235 Cr | 9.65 | |
| Mar2022 | ₹214 Cr | - | |
Compare Revenue of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹2,056.2 Cr | -1.3% | 17.5% | 29.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | -1.3% |
17.5% |
29.1% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses